The Reply - 26/07/17
| Funding: None. |
|
| Conflict of Interest: VLS received research grants from clopidogrel and prasugrel manufacturers, lecture fees from clopidogrel and prasugrel manufacturers, and consultant fees from clopidogrel, prasugrel, and ticagrelor manufacturers. He sold a patent on prasugrel to Eli Lilly and Company (Indianapolis, Ind). TAM has no conflicts to report. |
|
| Authorship: Both authors had access to the data and played a role in the writing of this manuscript. |
Vol 130 - N° 8
P. e357-e358 - août 2017 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?
